2021
DOI: 10.1016/j.gene.2020.145363
|View full text |Cite
|
Sign up to set email alerts
|

Expression of ERV3-1 in leukocytes of acute myelogenous leukemia patients

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 36 publications
0
9
0
Order By: Relevance
“…Many studies have demonstrated a potential implication of ERVs in a wide spectrum of human malignancies including hematologic malignancies and solid tumors. High expression levels of the Env protein of ERV-3-1 were found in all patients with Acute myeloid leukemia (AML) included in one cohort while this effect was more specific for bone marrow and blood cells and was closely associated with a myeloid phenotype of AML in this study (208). Concerning hematologic malignancies, Myelodysplastic syndrome (MDS) is a heterogeneous category of hematological diseases that are recognized predisposition factors for the development of myeloid lineage malignancies, most commonly myeloid leukemia (209).…”
Section: Hervs and Human Cancer: Link Therapeutic And Prognostic Perspectivesmentioning
confidence: 48%
“…Many studies have demonstrated a potential implication of ERVs in a wide spectrum of human malignancies including hematologic malignancies and solid tumors. High expression levels of the Env protein of ERV-3-1 were found in all patients with Acute myeloid leukemia (AML) included in one cohort while this effect was more specific for bone marrow and blood cells and was closely associated with a myeloid phenotype of AML in this study (208). Concerning hematologic malignancies, Myelodysplastic syndrome (MDS) is a heterogeneous category of hematological diseases that are recognized predisposition factors for the development of myeloid lineage malignancies, most commonly myeloid leukemia (209).…”
Section: Hervs and Human Cancer: Link Therapeutic And Prognostic Perspectivesmentioning
confidence: 48%
“… 81 More importantly, the presence of the ERV‐3‐1 protein was confirmed on the surface of leukemic cells of all myeloid‐phenotype AML patients and the majority of monocytic‐phenotype patients in immunohistochemical studies. 81 ERV‐3‐1 upregulated expression was correlated to chromosome 8 trisomy leukemic genotype, however, this correlation was not significant in the immunohistochemical study for the identification of the ERV‐3‐1 protein on leukemic cells. 81 Deregulated HERV expression patterns are recognized in multiple AML differentiation types.…”
Section: Herv Participation In Malignancies and Clinical Implicationsmentioning
confidence: 87%
“…Additionally, the expression of ERV‐3‐1 is upregulated in the blood and bone marrow cells of patients with AML, and this upregulation was more prominent in the myeloid lineage compared to the monocytic one 81 . More importantly, the presence of the ERV‐3‐1 protein was confirmed on the surface of leukemic cells of all myeloid‐phenotype AML patients and the majority of monocytic‐phenotype patients in immunohistochemical studies 81 .…”
Section: Herv Participation In Malignancies and Clinical Implicationsmentioning
confidence: 90%
See 1 more Smart Citation
“…Human ERV-K (HERV-K) is actively expressed in human melanoma, and their protein expression, as well as particle formation, have been reported (3,4). ERV3-1, an env gene of HERV-R, is also reported to be expressed in colorectal cancers (5) and acute myelogenous leukemia (6). In mice, active expression of an ERV called MelARV has been reported in B16/BL6 melanoma cells (7,8).…”
Section: Introductionmentioning
confidence: 99%